Icosagen Cell Factory OÜ was established in 2005. It is a CRO (Contract Research Organization)-type company, developing novel technologies and providing research services to the biopharmaceutical and biotechnology industries and to academia. A portfolio of proprietary technologies (e.g. QMCF Technology for protein production) and custom-tailored services for protein, antibody, VLP. etc., production are offered by Icosagen Cell Factory.
Icosagen Technologies Inc. was established in 2015, in order to give US customers access to Icosagen`s technologies and services.

IcoPark OÜ was established in 2013, in order to develop the infrastructure of the Icosagen Group.

For our customers, we provide opportunities and contributions to make their activities simpler and more effective, more efficient and less risky.

Internally, we continuously develop and improve our products, technologies and services to provide additional innovation and benefit to our customers. Our company has over 100 skilled and committed professional team members. The management system complies with the requirements of the ISO 9001:2015 standard.

We are a leading biotechnology group in Estonia having provided custom-tailored services as well as catalogue products for global customers in academia, pharma, biotech and industry for several years.

Icosagen AS Downloads

Human CDNF ELISA kit - Brochure

Human MANF ELISA kit - Brochure

Human RNase 7 ELISA kit - Brochure

Human CD48 ELISA kit - Brochure

Mouse CD48 ELISA kit - Brochure